Reversal of MRP-Mediated Multidrug Resistance in Human Lung Cancer Cells by the Antiprogestatin Drug RU486
- 19 May 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 258 (3) , 513-518
- https://doi.org/10.1006/bbrc.1999.0671
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Direct Interaction between a Quinoline Derivative, MS-209, and Multidrug Resistance Protein (MRP) in Human Gastric Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)Blood, 1999
- Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.Journal of Clinical Oncology, 1998
- Multidrug resistance mediated by the multidrug resistance protein (MRP) geneBiochemical Pharmacology, 1996
- The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P‐glycoprotein functionFEBS Letters, 1994
- Multidrug Resistance in the Laboratory and ClinicPublished by Elsevier ,1994
- Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cellsBritish Journal of Cancer, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Multidrug resistance (mdr) genes in human cancerBritish Journal of Cancer, 1991